<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="371820" id="root" date="1997-02-12" xml:lang="en">
<title>UK: BTG says AHP patent boosts income flow.</title>
<headline>BTG says AHP patent boosts income flow.</headline>
<dateline>LONDON 1997-02-12</dateline>
<text>
<p>British technology company BTG Plc said on Wednesday that the earlier than expected approval of an American Home Products Corp haemophilia drug in the U.S. would extend the flow of royalty patents to BTG.</p>
<p>Earlier AHP's wholly-owned subsidiary Genetics Institute said the Food and Drug Administation (FDA) had approved the marketing of BENEFIX, which is used for treating haemophilia B.</p>
<p>BTG said approval of the drug, which uses BTG technology, was two years earlier than expected at the time of BTG's 1995 flotation. Shares in BTG were sharply higher in late afternoon trading, rising 9.2 percent or 43-1/2 pence to 515 pence.  </p>
<p>Shares in the company have risen by 14 percent since the start of the year and by 131 percent since the beginning of 1996.</p>
<p>BTG said BENEFIX is the sixth drug using its licensed technology to have been approved for sale since it floated. Other BTG-licensed products include Zeneca Group Plc's cancer drug Tomudex.</p>
<p>BTG said BENEFIX avoids the risk found in other Factor IX products of transmitting blood-borne viruses such as hepatitis. Factor IX is a key protein in blood clotting.</p>
<p>-- London Newsroom +44 171 542 7717</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="UK">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-02-12"/>
  </code>
  <code code="USA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-02-12"/>
  </code>
</codes>
<codes class="bip:industries:1.0">
  <code code="I25700">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-02-12"/>
  </code>
  <code code="I83700">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-02-12"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C13">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-02-12"/>
  </code>
  <code code="C22">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-02-12"/>
  </code>
  <code code="C33">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-02-12"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-02-12"/>
  </code>
</codes>
<dc element="dc.date.created" value="1997-02-12"/>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1997-02-12"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location" value="LONDON"/>
<dc element="dc.creator.location.country.name" value="UK"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
